Drug intelligence / Profile preview

KLF6 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

KLF6 siRNA is a small interfering RNA (siRNA) designed to target and silence the expression of Krüppel-like factor 6 (KLF6), a zinc finger transcription factor. In preclinical research, KLF6 siRNA is utilized to investigate the role of KLF6 in various physiological and pathological processes, including lipid metabolism, cell differentiation, inflammation, and tissue repair. For instance, in autoimmune hepatitis (AIH) models, silencing KLF6 in regulatory T cells (Tregs) has been shown to downregulate intracellular lipid peroxidation and ameliorate Treg suppressive function, suggesting therapeutic potential for rebalancing Treg lipid metabolism in AIH.

Other names
KLF6-specific siRNAKLF-6-specific siRNAKLF 6-specific siRNAKLF6-targeted siRNAKLF-6-targeted siRNAKLF 6-targeted siRNAKlf6 siRNAKlf-6 siRNAKlf 6 siRNA
02

Targets

KLF6 (Krüppel-like factor 6)

Beyond the preview

Go deeper on KLF6 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLF6 siRNA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call